American Red Cross and ZOLL Announce Strategic Agreement to Help Enhance CPR and AED Training.
CHELMSFORD, Mass.--(BUSINESS WIRE)--Feb. 12, 2004
ZOLL Medical Corporation (NASDAQ: ZOLL), a manufacturer of non-invasive cardiac resuscitation devices, today announced an agreement with the American Red Cross to make ZOLL's existing automated external defibrillator (AED), the AED Plus(TM), more accessible to the public and businesses nationwide through the Red Cross network of local chapters, as an accessory to CPR and AED training. The Red Cross will focus on increasing defibrillation awareness by providing access to AEDs and AED ancillary items in conjunction with its mission to provide lifesaving CPR/AED training.
According to Richard A. Packer, President and Chief Executive Officer of ZOLL, "This agreement is an important milestone in expanding our reach into the growing AED market and giving us access to additional training resources nationwide. The Red Cross is one of the largest first aid, CPR, and AED training organizations, reaching nearly 12 million people annually through its network of more than 900 chapters. Working with the Red Cross affords ZOLL, and other AED manufacturers, the opportunity to potentially educate thousands of people about defibrillation and allows us to increase the number of defibrillators available to the public."
"Our goal is to educate and train as many people as possible in lifesaving first aid, CPR, and AED use, and have every American within four minutes of an AED and someone trained to use it," said Scott Conner, Vice President, Preparedness, American Red Cross. "Combined CPR and AED training is one of the most important investments organizations can make to protect the public and help increase survival rates. The Red Cross is dedicated to working with ZOLL, and other AED providers, to raise awareness about the need for the increased public access to AEDs."
The Red Cross approach to CPR and AED training involves helping people overcome their reluctance and hesitancy to get involved and take action when an emergency occurs. Bystander interventions, such as CPR coupled with rapid AED usage, are likely to increase Sudden Cardiac Arrest (SCA) survival rates. Sudden Cardiac Arrest is usually due to abnormal heart rhythms that cause the heart's electrical impulses to suddenly become chaotic, causing the heart's pumping action to stop abruptly.
ZOLL supports this approach to CPR and AED training, and has developed the ZOLL AED Plus to coach lay rescuers through all of the actions they must take to help an SCA victim survive. It is the only AED that provides vital visual and audio prompts to ensure effective CPR and defibrillation. It is also the only AED that helps rescuers achieve the recommended depth and rate of chest compressions during CPR. By creating a device that focuses on every step of the rescue process, ZOLL hopes to differentiate its AED from others on the market.
About the American Red Cross
The American Red Cross is dedicated to helping make families and communities safer at home and around the world. Governed by volunteers and supported by community donations, the American Red Cross is a nationwide network of more than 900 chapters and Blood Services regions dedicated to saving lives and helping people prevent, prepare for and respond to emergencies. Led by 1.2 million volunteers and 32,000 employees, the Red Cross annually mobilizes relief to families affected by more than 67,000 disasters, trains almost 12 million people in lifesaving skills and exchanges more than a million emergency messages for U.S. military service personnel and their families. The Red Cross is the largest supplier of blood and blood products to more than 3,000 hospitals across the nation and also assists victims of international disasters and conflicts at locations worldwide.
ZOLL Medical Corporation (NASDAQ: ZOLL), with worldwide headquarters in Chelmsford, Massachusetts, designs, manufactures, and markets resuscitation solutions. Pacing and defibrillation devices, including ZOLL's M Series(TM) and AED Plus(TM), and LIFECOR, Inc.'s LifeVest(TM) Wearable Defibrillator; and circulatory assist devices such as Advanced Circulatory Systems, Inc.'s ResQPOD(TM) Circulatory Enhancer and Revivant Corporation's AutoPulse(TM); are used by health care professionals, emergency medical service providers, and first responders to diagnose and treat cardiac arrest wherever it may occur. ZOLL also designs and markets software that automates the collection and management of both clinical and non-clinical data. ZOLL has sales operations in Australia, Austria, Canada, China, France, Germany, India, The Netherlands, Russia, the United Kingdom, and the United States, and business partners in all of the world's major markets. For more information about ZOLL, its products and partners, visit www.zoll.com or call 978-421-9655.
Certain statements contained in this press release, including statements regarding the anticipated development of the Company's business, our ability to differentiate our products from other on the market, and other statements contained herein regarding matters that are not historical facts, are "forward-looking" statements (as defined in the Private Securities Litigation Reform Act of 1995). Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, those factors discussed in the section entitled "Risk Factors" in the Company's Annual Report on Form 10-K filed with the SEC on December 19, 2003.
Copyright (C) 2004 ZOLL Medical Corporation. All rights reserved. 269 Mill Road, Chelmsford, MA 01824-4105. AED Plus and M Series are trademarks of ZOLL Medical Corporation. The LifeVest System is a trademark of LIFECOR, Inc. The ResQPOD is a trademark of Advance Circulatory Systems, Inc. The AutoPulse Resuscitation System is a trademark of Revivant Corporation. ZOLL is a registered trademark of ZOLL Medical Corporation. All trademarks are property of their respective owners.
|Printer friendly Cite/link Email Feedback|
|Date:||Feb 12, 2004|
|Previous Article:||Dr. Mark Popovsky Appointed to Panel on Blood Transfusion Services in Support of President Bush's Emergency Plan for AIDS Relief.|
|Next Article:||GlobeTrac Signs Re-Seller Agreement with Norte Innovacion.|